study to compare treatment options in for warts using MMR vaccine and vitamin D injectio
Phase 2
- Conditions
- Health Condition 1: B079- Viral wart, unspecified
- Registration Number
- CTRI/2023/08/056461
- Lead Sponsor
- sushil kumar singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age >12 years of either sex
2.Not received any systemic or oral therapy for management of warts in the last 4 weeks.
3.Willing to give consent for inclusion.
4.Willing for 3 weekly follow up.
Exclusion Criteria
1.Patients under any systemic or topical treatment of warts within the last four weeks.
2.Patients with a past history of an allergic response to MMR or any other vaccine or Vitamin D.
3.Immunosuppressed patients
•Pregnancy and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical improvement will be graded as a full response, an excellent response, a fair response, a poor response, or no response based on the patients and physicians global evaluation using a visual analogue scale score at each visit, with baseline clinical photographs serving as controls. After each treatment session, the immediate and delayed adverse effects of MMR vaccination.Timepoint: 3 weekly monitoring after each dose and follow up at 3 months.
- Secondary Outcome Measures
Name Time Method 1.To determine the frequency & location of warts in patients visiting the outpatient department of dermatology at CNMC, Kolkata. <br/ ><br>2.To determine the adverse effects associated with intralesional injection of MMR and vitamin D. <br/ ><br>Timepoint: at three weekly visits